Tuesday, June 23, 2020


         One Possible Approach to an Approved Vendor List

         Based on part / component criticality (to patient / end user / clinician).    

               Based on product risk, supplier / vendor audit results, incoming QC trend data,    
               and other factors, a list of approved vendors, and their criticality should be 
               established and maintained by QA, separately, or in each vendor’s file. 
                 
Criticality (based on risk to the patient / end user / clinician):
   
Criticality Category
Ranking
Category
01.  Lab services – contracted – clean room 
       / controlled manufacturing area testing,   
       biocompatibility, EO / BI / gamma
       validation and testing, GMP
       compatibility issues
High (Major)
Services
02.  Calibration services -- contracted
High
Services
03.  Patient fluid path contact 
High
Parts
04.  Tissue, bone and dentin contact
High
Parts
05.  Sterile barrier
High
Parts
06.  Sterilization services – contracted
High
Services
07.  Patient contact, general
Moderate
Parts
08.  Test equipment, tooling, fixturing  
       manufacturers – company validated
Moderate
Services / Equipment
09.  Equipment, tooling, fixturing;    
       manufacturers – company validated
Low (Minor)
Services / Equipment
10.  No patient contact
Low
Parts
11.  Manufacturing Materials – fully    
       removed during processing (validated)
Low
Parts




Ranking explained (reference:Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document”, May 11, 2005):


Ranking:
Explanation:

Major
A failure or latent flaw could directly result in death or serious injury to the patient or operator. The level of concern is also Major if a failure or latent flaw could indirectly result in death or serious injury of the patient or operator through incorrect or delayed information or through the action of a care provider.
Moderate
A failure or latent design flaw could directly result in minor injury to the patient or operator. The level of concern is also Moderate if a failure or latent flaw could indirectly result in minor injury to the patient or operator through incorrect or delayed information or through the action of a care provider.
Minor
Failures or latent design flaws are unlikely to cause any injury to the patient or operator


     














      6.11  Critical Vendors:  Suppliers / vendors ranked “High / Major” on the above tables     
               are determined to be “critical”.  Critical suppliers are to be subjected to an initial
               site (or virtual) audit.  Follow-up reviews / frequency will be determined by patient /
               user risk factors as mentioned above and/or a Product Risk Management File, and the
               quality of their deliverables, maintenance of their CGMP compliance and/or
               certifications. 

               The type of vendors to be considered “critical” could consist of: 
               Independent test labs, calibration services, contract sterilizers, manufacturers of   
               critical / high risk components, compliance consultants, Notified-Bodies (generally
               will not be audited by the company, as they are subject to their own competent
               authority oversight), and similar. 

               Moderate risk vendors will be subject to an initial desk audit (see Attachment 1),
               supplemented by any additional follow up phone interviews (document in memo to    
               file) and/or e-mail correspondence (initialed and dated)

               All High and Moderate vendors will be subject to a periodic review, usually
               annually, as to performance, retention or replacement, and/or need for any
               supplemental re-audit / re-inspection; documented by a memo to their file.  

               Low risk ranked vendors will be subject to review / action if any deliverable is found
               non-conforming, and such review will be included in the NCMR or other CAPA
               documentation.

              --  jel@jelincoln.com 

No comments:

Post a Comment